Individual Qualified Health Plans 5 Tier Commercial Formulary (List of Covered Drugs)

Transcription

1 Effective: September 11, 2017 What is the Drug List? Also called a formulary by doctors and pharmacists, the Drug List is an extensive list of safe and effective, FDA-approved, brand name and generic prescription drugs used to treat the most common medical conditions. The Health First Pharmacy and Therapeutics Committee (P&T), a panel of physicians and pharmacists, developed our Drug List and updates it regularly. The list includes quality drugs available to you at a reasonable cost. Only those medications that have successfully passed federally required clinical testing and evaluation and have been proven effective are included. The P&T Committee reviews and evaluates all available literature about a drug when updating the list. About Tiers Most covered prescription drugs will be categorized into one of five cost-sharing tiers. Drug costs vary widely, even though several different medications may be used to treat the same condition. What you pay for the prescription depends upon what tier the drug is listed in. Health First Health Plans and Insurance (The Plan) offers many benefit plans that can vary in coverage for each tier. Details about your specific benefit for each tier are included in the The Plan Summary of Benefits. Prescriptions that exceed a 30 day supply will default to a 90 day supply copay (this does not apply to coinsurances). For coinsurances, you will always pay a percentage of the total cost after the applicable deductible is met. Small Group Qualified Health Plans Individual Qualified Health Plans 5 Tier Commercial Formulary (List of Covered Drugs) Tier 1 (T1) - Includes low-cost preferred generic drugs. Tier 2 () - Includes higher-cost generic drugs. Tier 3 () - Includes preferred brand-name drugs and some higher-cost generic drugs. Tier 4 () - Includes higher-cost non-preferred brand-name drugs and generic drugs (some plans may be limited to a 30-day supply). Tier 5 (T5 SP) - Includes higher-cost biologics or prescription drugs that require close monitoring for safety and efficacy. Preventive Care () - Includes some select preventive products, prescription medications and specific over-the-counter (OTC) medications available to you at no cost-sharing ($0) when applicable conditions are met. HIV/AIDS Drugs Safe Harbor (SH) Anti-retorviral medications used to treat HIV/AIDS have different copays than those on the The Plan s Summary of Benefits assigned to tiers as indicated below. Safe Harbor Tier 1 Copay (T1): $40 per 30 day supply Safe Harbor Tier 2 Copay (): $55 per 30 day supply Safe Harbor Tier 3 Copay (): $70 per 30 day supply Safe Harbor Tier 4 Copay (): $150 per 30 day supply Safe Harbor Tier 5 Copay (T5): $200 per 30 day supply _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 1

2 Generic drugs are prescription drugs that have the same active ingredients as brand drugs and are prescribed for the same reasons. When the patent expires on a brand name drug, the FDA permits new manufacturers to produce an equivalent of the brand name drug and make it available to the public. Generally, more than one manufacturer will produce generic versions, although often the same pharmaceutical firm that produces the brand name drug also makes the generic version. This prompts competitive pricing of the generic version and usually results in a less expensive drug that is as safe and effective as the brand name drug. What will my expenses be? Every plan is different, and your financial obligation will vary based on your specific plan. You are responsible for any cost sharing your plan requires. What is a deductible? A deductible is a set dollar amount that you must pay each calendar year before your health plan starts paying. If your plan includes an integrated pharmacy deductible, it will accumulate with your innetwork medical deductible. Refer to your plan documents to see when your deductible starts over for your plan. What is the difference between a copayment and coinsurance? Copayments and coinsurance are types of member cost sharing, and they represent the portion of covered prescription expenses members must pay. A copayment is a flat dollar amount while coinsurance is a percentage of the total allowable charges. What does out-of-pocket maximum mean? The out-of-pocket maximum protects you from catastrophic medical and prescription drug expenses by limiting how much you have to pay during the benefit year. Your cost sharing for covered prescription drugs (deductible, coinsurance and copayment) all accumulate with your in-network medical out-of-pocket maximum. Refer to your plan documents to see when your out-of-pocket maximum starts over for your plan and to verify the specific cost sharing you have for specific tiers. The Drug List is subject to change In order to continue to offer a safe and cost effective selection of prescription drugs, The Plan periodically makes changes to the Drug List. These changes may include removing medications, adding restrictions, and/or covering a drug at a higher tier. Updated formularies are posted to the website as changes are made. The following list represents some of the most common scenarios in which changes to drug coverage will occur: Throughout the year, new medications are approved by the FDA. It is the policy of The Plan that new drugs will be excluded for 6 months from the date of FDA approval, during which time the Health First P&T Committee can review the drug for safety and efficacy. When a medication is withdrawn from the market due to safety reasons or if it becomes available over-the-counter (OTC). At the time that a medication on the HFHP Drug List becomes available OTC, it may be excluded from coverage from that point forward. When a brand-name prescription drug loses its patent and the equivalent generic form is added to the Drug List, the brand-name drug may be moved to Tier 4 or removed from the formulary. This formulary is current as of September 11, To get updated information about covered drugs, please visit our Web site at myhfhp.org or call Customer Service toll-free at (TTY/TDD relay: ) Monday through Friday from 8 a.m. to 6 p.m. Are there any restrictions on my coverage? Some covered drugs may have additional requirements or limits on coverage. These requirements and limits may include: Prior Authorization: The Plan requires you and/or your physician to get prior authorization for certain drugs. This means that you will need to get approval from us before you fill your prescriptions. In order for the plan to pay for these drugs, the physician ordering the prescription is required to submit all medical information to The Plan documenting the medical necessity. These drugs are identified in the Drug List. Step Therapy: In some cases, The Plan requires you to first try certain drugs to treat your medical condition before we will cover _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 2

3 another drug for that condition. For example, if Drug A and Drug B both treat your medical condition, we may not cover Drug B unless you try Drug A first. If Drug A does not work for you, we will then cover Drug B. A complete list of drugs which require step therapy is listed in the reference table on page 6. Quantity Limits: For some covered drugs, there is a maximum amount that will be covered by The Plan over a certain period of time. For example, The Plan covers 30 tablets every 30 days or 90 tablets every 90 days for TRADJENTA. How can I make the most of my prescription drug benefit? Prescription drug costs continue to rise every year and can represent a significant part of your healthcare expenses. The Plan helps you pay for your medications by sharing the cost with you and providing substantial discounts for covered medications. To help you manage your drug costs, here are some money-saving tips to consider: Use generic medications whenever possible. Generic drugs are the chemical equivalent of brand name drugs and are just as effective in most cases. If you take generic drugs you will generally pay less. Talk to your doctor to see if switching to a generic equivalent of any brand name drug you are taking is appropriate. Please see the list of drugs below to determine which generic drugs are included in lower cost-sharing tiers. What if my drug is not on the Formulary? If your drug is not included in this formulary, you should first contact Customer Service and confirm that your drug is not covered. If you learn that The Plan does not cover your drug, you have two options: You can ask Customer Service for a list of similar drugs that are covered by The Plan. When you receive the list, show it to your doctor and ask if switching to a covered medication is appropriate. You can ask your physician to send The Plan information requesting we make an exception and cover your drug. If The Plan approves the request for an exception to the formulary, the approved drug will be covered at the Tier 4 cost share unless the cost of the medication is greater than $500 per month, then it will be covered at the Tier 5 cost share. Excluded drugs The Plan does not provide coverage for all drugs. In addition to the drugs marked excluded in this drug list, newly FDA approved drugs are not covered unless the Health First P&T Committee in its sole discretion approves these drugs for coverage. The Plan will automatically exclude a particular drug if a generic version becomes available and an entire class of drugs if a particular drug within that class becomes available over the counter. The following are NOT covered by The Plan: Compounded drugs Cosmetics or any drugs used for cosmetic purposes Diabetic supplies, blood glucose monitors and test strips other than those manufactured by Abbott under the product name Freestyle, Precision, and test strips Erectile dysfunction drugs (such as Viagra) Infertility drugs (such as Clomid) Some injectables (except insulin, Imitrex, and those requiring prior authorization) Most multivitamins and nutritional supplements (except prescription pre-natal vitamins and products covered under the Preventive Care benefit) Nonprescription supplies or substances Most Over-the-counter (OTC) medications (except products covered under the Preventive Care benefit) ), or any drug for which a similar over-the-counter version is available All new drugs approved by the FDA will be excluded from the preferred drug list/formulary unless the Health First P&T Committee, in its sole discretion, decides to waive this exclusion for a particular drug. Support garments Syringes, needles, or other disposable supplies (except those used with insulin) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 3

4 Preventive Care Medications: $0 Cost-share Medications and Products The Affordable Care Act (ACA), commonly known as health care reform, was signed into federal law in The ACA requires private insurers to cover certain preventive services without any patient cost-sharing (i.e., copayments, coinsurance and deductible) when they are delivered by a network provider. The Department of Health and Human Services (HHS) has recognized several recommending bodies (e.g., United States Preventive Services Task Force [USPSTF], Advisory Committee on Immunization Practices [ACIP], and Health Resources and Services Administration [HRSA]) who have identified several medication categories that fall within the preventive health mandate. The following products, prescription medications and specific over-the-counter (OTC) medications (notated in Tier throughout this formulary) are available to our members at no ($0) cost-sharing when: Prescribed by a health care professional (all prescription and OTC medications will require a prescription) Age and/or gender appropriate This list will be reviewed periodically and is subject to change. Medicine/Product Category and Who is Covered Examples of the Medicine/Product Covered Aspirin Individuals < 60 years Aspirin products < 325 MG Fluoride Children age 6 months through 5 years Folic Acid Women only through age 50 years Vitamin D Supplements Adults > 65 years of age Immunizations The age of coverage varies based on the vaccine product prescribed and recommendations by the U.S. Centers for Disease Control and Prevention Contraceptive Methods Women only, through age 50 years Fluoride Chewable Tablet 0.25 MG and 0.5 MG; Fluoride Drops MG, 0.25 MG and 0.5 MG; Multivitamin W/ Fluoride Chewable 0.25 MG and 0.5 MG; Multivitamin W/ Fluoride Drops 0.25 MG and 0.5 MG; Multivitamin W/ Fluoride Suspension 0.25 MG and 0.5 MG Folic Acid Tablet 0.4 MG and 0.8 MG; Prenatal Multivitamins W/ Folic Acid (0.4 MG and 0.8 MG) Vitamin D 1,000 Units Or Less Per Dose Unit; Calcium With Vitamin D (1,000 Units Or Less Per Dose Unit) Covered immunizations include those that are routine vaccines recommended by the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention and that meet the US Food and Drug Administration approved indications for age and/or gender limitations. Coverage also includes non-routine immunizations used to prevent other illnesses such as typhoid, yellow fever, and Japanese encephalitis. Covered products include one or more Food and Drug Administration (FDA) approved 16 contraceptive methods available through the prescription drug benefit, including: _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 4

5 Medicine/Product Category and Who is Covered Primary Prevention of Breast Cancer For women > 35 years of age who meet criteria Raloxifene is covered for only those who are postmenopausal If you are 35 years of age or older and have not had breast cancer, talk to your doctor about your risk. If appropriate, your doctor may offer to prescribe one of these risk-reducing medications. You or your doctor can then submit a Prior Authorization request to get the medication approved at $0 cost-share if coverage criteria are met. Tobacco Cessation Adults 18 and older Must receive counseling and have prescription from a health care provider Up to two, 3-month treatment courses are covered at no cost each year (any additional treatment may be subject to a costshare) Medications used to prepare for Colonoscopy Adults > 50 and < 75 years of age Limit of 2 prescriptions per year Examples of the Medicine/Product Covered Generic OTC spermicide and legend diaphragms; Today contraceptive sponge; Female condom; Femcap ; Generic oral, transdermal and intramuscular hormonal methods; Nuvaring ; Generic, OTC emergency contraceptives and Ella ; The intrauterine systems Mirena and Paragard ; The intradermal agent, Nexplanon Tamoxifen Raloxifene Soltamox (Liquid Tamoxifen) Zyban (Generic); Chantix; Nicotine Replacement Products Generic products such as: Bisacodyl; Magnesium Citrate; Milk Of Magnesia; PEG 3350-Electrolyte If you have any questions regarding your eligibility for preventive care medications and preventive contraceptive coverage, please contact your employer or call Customer Service toll-free at (TTY/TDD relay: ) Monday through Friday from 8 a.m. to 6 p.m _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 5

6 Step Therapy Reference Table Drug Name ALMOTRIPTAN, FROVATRIPTAN, NARATRIPTAN, RELPAX, ZOLMITRIPTAN, ZOLMITRIPTAN ODT, ZOMIG NASAL APIDRA, HUMALOG INVOKANA, FARXIGA ULORIC SYMBICORT VIIBRYD Drug that must be tried first Sumatriptan, rizatriptan in the last 180 days Novolog in the last 180 days Jardiance in the last 180 days Allopurinol in the last 180 days Advair in the last 180 days Trial of any two (2) of the following drugs: bupropion, citalopram, duloxetine, escitalopram, fluoxetine, mirtazapine, paroxetine, sertraline, trazodone, venlafaxine in the last year _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 6

7 Formulary Changes Drug Name Change Previous Tier New Tier Effective Date New Requirements/ Limits Amitiza Addition Tier 3 9/11/2017 QL (60 EA per 30 days) amitriptyline-chlordiazepoxide Addition Tier 2 9/11/2017 MD ANDROGEL TRANSDERMAL GEL IN METERED-DOSE PUMP ANDROGEL TRANSDERMAL GEL IN PACKET Addition Quantity Limit Tier 3 Tier 3 9/11/2017 PA; MD; QL (150 GM per 30 days) Addition Quantity Limit Tier 3 Tier 3 9/11/2017 PA; MD; QL (60 GM per 30 days) AUSTEDO ORAL TABLET 12 MG Addition Tier 5 9/11/2017 PA; MD; QL (120 EA per 30 days) AUSTEDO ORAL TABLET 6 MG, 9 MG Addition Tier 5 9/11/2017 PA; MD; QL (60 EA per 30 days) Bavencio Addition Tier 5 9/11/2017 PA; MD Belsomra Addition Tier 4 9/11/2017 PA chlordiazepoxide-clidinium Addition Tier 3 9/11/2017 COSENTYX (2 SYRINGES) SUBCUTANEOUS SYRINGE 150 MG/ML COSENTYX PEN (2 PENS) SUBCUTANEOUS PEN INJECTOR 150 MG/ML COSENTYX PEN SUBCUTANEOUS PEN INJECTOR 150 MG/ML Addition Tier 5 9/11/2017 PA; MD Addition Tier 5 9/11/2017 PA; MD Addition Tier 5 9/11/2017 PA; MD _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 7

8 Formulary Changes Drug Name Change Previous Tier New Tier Effective Date New Requirements/ Limits COSENTYX SUBCUTANEOUS SYRINGE 150 MG/ML Addition Tier 5 9/11/2017 PA; MD desvenlafaxine Addition Tier 4 9/11/2017 MD desvenlafaxine fumarate Addition Tier 4 9/11/2017 MD DIAZEPAM INTENSOL ORAL CONCENTRATE 5 MG/ML Addition Tier 4 9/11/2017 PA diazepam oral concentrate 5 mg/ml Addition Tier 2 9/11/2017 PA diazepam oral solution 5 mg/5 ml (1 mg/ml) Addition Tier 4 9/11/ diazepam oral tablet 10 mg Addition Tier 2 9/11/2017 QL (120 EA per 30 days) diazepam oral tablet 2 mg, 5 mg Addition Tier 4 9/11/2017 QL (90 EA per 30 days) doxazosin Increase Quantity Limit Tier 2 Tier 2 9/11/2017 QL(60 EA per 30 days) Dupixent Addition Tier 5 9/11/2017 PA; MD Eliquis Lower Tier Tier 4 Tier 3 9/11/2017 Epclusa Addition Tier 5 9/11/2017 PA Esbriet Addition Tier 5 9/11/2017 PA; MD Kisqali Addition Tier 5 9/11/2017 PA; MD _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 8

9 Formulary Changes Drug Name Change Previous Tier New Tier Effective Date New Requirements/ Limits Kisqali Femara Co-Pack Addition Tier 5 9/11/2017 PA; MD Lantus Lantus Solostar Lower Tier; Remove Step Therapy; Addition of Quantity Limit Lower Tier; Remove Step Therapy; Addition of Quantity Limit Tier 4 Tier 3 9/11/2017 QL(60 ML per 30 days) Tier 4 Tier 3 9/11/2017 QL(60 ML per 30 days) Linzess Addition Tier 3 9/11/2017 MD; QL (30 EA per 30 days) lorazepam oral concentrate 2 mg/ml Addition Tier 2 9/11/ lorazepam oral tablet 0.5 mg, 1 mg Addition Tier 2 9/11/2017 QL (180 EA per 30 days) lorazepam oral tablet 2 mg Addition Tier 2 9/11/2017 QL (150 EA per 30 days) Normal Saline Flush Addition Tier 2 9/11/2017 prochlorperazine maleate Addition Tier 2 9/11/2017 Selzentry Addition Tier 3 9/11/2017 QL(120 EA per 30 days) sodium chloride 0.9 % Addition Tier 2 9/11/2017 tazarotene Addition Tier 3 9/11/2017 terazosin Increase Quantity Limit Tier 2 Tier 2 9/11/2017 QL(60 EA per 30 days) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 9

10 Formulary Changes Drug Name Change Previous Tier New Tier Effective Date New Requirements/ Limits testosterone cypionate intramuscular oil 100 mg/ml testosterone cypionate intramuscular oil 200 mg/ml testosterone enanthate intramuscular oil 200 mg/ml testosterone transdermal gel 50 mg/5 gram (1 %) testosterone transdermal gel in metereddose pump 12.5 mg/ 1.25 gram (1 %) testosterone transdermal gel in packet 1 % (25 mg/2.5gram) testosterone transdermal gel in packet 1 % (50 mg/5 gram) Remove PA; Addition Quantity Limit Remove PA; Addition Quantity Limit Remove PA; Addition Quantity Limit Remove PA; Addition Quantity Limit Remove PA; Addition Quantity Limit Remove PA; Addition Quantity Limit Remove PA; Addition Quantity Limit Tier 3 Tier 3 9/11/2017 MD; QL (10 ML per 28 days) Tier 3 Tier 3 9/11/2017 MD; QL (4 ML per 28 days) Tier 3 Tier 3 9/11/2017 QL (5 ML per 28 days) Tier 3 Tier 3 9/11/2017 MD; QL (60 GM per 30 days) Tier 3 Tier 3 9/11/2017 MD; QL (75 GM per 30 days) Tier 3 Tier 3 9/11/2017 MD; QL (150 GM per 30 days) Tier 3 Tier 3 9/11/2017 MD; QL (60 GM per 30 days) tetrabenazine Addition Tier 5 9/11/2017 PA Toujeo SoloStar Addition Tier 3 9/11/2017 QL(21 ML per 30 days) Xarelto Lower Tier Tier 4 Tier 3 9/11/2017 Zohydro ER Addition Tier 4 9/11/2017 QL(60 EA per 30 days) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 10

11 Health First Health Plans and Insurance Formulary The formulary provides coverage information about some of the drugs covered by The Plan. If you have trouble finding your drug in the list, turn to the Index that begins on page 132. The first column of the chart lists the drug name. Brand name drugs are capitalized (e.g., PRADAXA) and generic drugs are listed in lower-case italics (e.g., lisinopril). The information in the Notes column tells you if The Plan has any special requirements for coverage of your drug. Specialty Drug (SP): Biologics or prescription drugs that may require close monitoring for safety and efficacy. Prior Authorization (PA): The Plan requires you or your physician to get prior authorization for certain drugs. This means that you will need to get approval from The Plan before you fill your prescriptions. If you don't get approval, the drug will not be covered. Quantity Limit (QL): Quantity Limits may also be listed. For example, 30 EA per 30 days would mean your coverage of this drug is limited to 30 pills every 30 days. Prescriptions written for more than the suggested Quantity Limits will only be honored up to the listed amount unless an exception is requested by your physician and approved by The Plan. Step Therapy (ST): In some cases, FHCA requires you to first try certain drugs to treat your medical condition before we will cover another drug for that condition. For example, if Drug A and Drug B both treat your medical condition, we may not cover Drug B unless you try Drug A first. If Drug A does not work for you, we will then cover Drug B. A complete list of drugs which require Step Therapy is listed in the reference table on page 6. Safe Harbor (SH): Anti-retorviral medications used to treat HIV/AIDS that may have different copays than those on the FHCA Summary of Benefits assigned to tiers. No Cost-Share (): Select preventive products, prescription medications and specific over-the-counter (OTC) medications available to our members at no cost-sharing ($0) when applicable conditions are met _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 11

12 ANALGESICS acetaminophen-caff-dihydrocod oral capsule mg acetaminophen-codeine oral solution 120 mg-12 mg /5 ml (5 ml), mg/5 ml, 240 mg-24 mg /10 ml (10 ml), 300 mg-30 mg /12.5 ml QL (2700 ML per 30 days) acetaminophen-codeine oral tablet mg, mg QL (240 EA per 30 days) acetaminophen-codeine oral tablet mg QL (180 EA per 30 days) almotriptan malate oral tablet 12.5 mg, 6.25 mg ST; QL (18 EA per 30 days) ascomp with codeine oral capsule mg QL (180 EA per 30 days) aspirin oral tablet 325 mg aspirin oral tablet,delayed release (dr/ec) 325 mg BAYER ASPIRIN ORAL TABLET 325 MG BUTALBITAL COMPOUND W/CODEINE ORAL CAPSULE MG BUTALBITAL COMPOUND-CODEINE ORAL CAPSULE MG butalbital-acetaminop-caf-cod oral capsule mg, mg QL (180 EA per 30 days) QL (180 EA per 30 days) QL (180 EA per 30 days) butalbital-acetaminophen oral tablet mg QL (180 EA per 30 days) butalbital-acetaminophen-caff oral capsule mg, mg QL (180 EA per 30 days) butalbital-acetaminophen-caff oral tablet mg QL (180 EA per 30 days) butalbital-aspirin-caffeine oral capsule mg QL (180 EA per 30 days) butorphanol tartrate injection solution 1 mg/ml, 2 mg/ml BUTRANS TRANSDERMAL PATCH WEEKLY 10 MCG/HOUR, 15 MCG/HOUR, 20 MCG/HOUR, 5 MCG/HOUR, 7.5 MCG/HOUR QL (4 EA per 28 days) QL Quantity Limit applies SP Specialty Drug No Cost Share ($0) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 12

13 codeine sulfate oral tablet 15 mg, 30 mg, 60 mg QL (180 EA per 30 days) codeine-butalbital-asa-caff oral capsule mg QL (180 EA per 30 days) diclofenac potassium oral tablet 50 mg diflunisal oral tablet 500 mg dihydroergotamine injection solution 1 mg/ml dihydroergotamine nasal spray,non-aerosol 0.5 mg/pump act. (4 mg/ml) ELMIRON ORAL CAPSULE 100 MG endocet oral tablet mg QL (180 EA per 30 days) endocet oral tablet mg, mg, mg QL (240 EA per 30 days) ERGOMAR SUBLINGUAL TABLET 2 MG fentanyl citrate buccal lozenge on a handle 1,200 mcg, 1,600 mcg, 200 mcg, 400 mcg, 600 mcg, 800 mcg fentanyl transdermal patch 72 hour 100 mcg/hr, 12 mcg/hr, 25 mcg/hr, 50 mcg/hr, 75 mcg/hr PA; QL (120 EA per 30 days) QL (15 EA per 30 days) frovatriptan oral tablet 2.5 mg ST; QL (18 EA per 30 days) hydrocodone-acetaminophen oral solution mg/15 ml QL (2700 ML per 30 days) hydrocodone-acetaminophen oral tablet mg, mg QL (180 EA per 30 days) hydrocodone-acetaminophen oral tablet mg, mg, mg, mg, mg QL (240 EA per 30 days) hydrocodone-acetaminophen oral tablet mg QL (84 EA per 30 days) hydrocodone-ibuprofen oral tablet mg, mg, mg QL (50 EA per 30 days) hydromorphone oral tablet 2 mg, 4 mg, 8 mg QL (180 EA per 30 days) hydromorphone oral tablet extended release 24 hr 12 mg PA; QL (30 EA per 30 days) QL Quantity Limit applies SP Specialty Drug No Cost Share ($0) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 13

14 hydromorphone oral tablet extended release 24 hr 16 mg, 32 mg, 8 mg QL Quantity Limit applies SP Specialty Drug No Cost Share ($0) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 14 PA; QL (30 EA per 30 days) ibuprofen-oxycodone oral tablet mg QL (28 EA per 30 days) ketorolac oral tablet 10 mg levorphanol tartrate oral tablet 2 mg QL (180 EA per 30 days) LITE COAT ASPIRIN ORAL TABLET 325 MG mefenamic acid oral capsule 250 mg meperidine oral tablet 100 mg, 50 mg QL (180 EA per 30 days) methadone oral tablet 10 mg, 5 mg QL (240 EA per 30 days) MIGERGOT RECTAL SUPPOSITORY MG QL (20 EA per 28 days) morphine concentrate oral solution 100 mg/5 ml (20 mg/ml) QL (600 ML per 30 days) morphine concentrate oral syringe 20 mg/ml QL (600 EA per 30 days) morphine oral solution 10 mg/5 ml QL (2700 ML per 30 days) morphine oral solution 20 mg/5 ml (4 mg/ml) QL (1350 ML per 30 days) morphine oral tablet 15 mg, 30 mg QL (180 EA per 30 days) morphine oral tablet extended release 100 mg, 15 mg, 30 mg, 60 mg QL (90 EA per 30 days) morphine oral tablet extended release 200 mg QL (60 EA per 30 days) naratriptan oral tablet 1 mg, 2.5 mg ST; QL (18 EA per 30 days) NUCYNTA ER ORAL TABLET EXTENDED RELEASE 12 HR 100 MG, 150 MG, 200 MG, 250 MG, 50 MG PA; QL (60 EA per 30 days) NUCYNTA ORAL TABLET 100 MG, 50 MG, 75 MG PA; QL (180 EA per 30 days) OPANA ER ORAL TABLET,ORAL ONLY,EXT.REL.12 HR 10 MG, 15 MG, 20 MG, 30 MG, 40 MG, 5 MG, 7.5 MG QL (60 EA per 30 days) oxycodone oral solution 5 mg/5 ml QL (5400 ML per 30 days) oxycodone oral tablet 10 mg, 15 mg, 20 mg QL (180 EA per 30 days) oxycodone oral tablet 30 mg QL (120 EA per 30 days)

15 oxycodone oral tablet 5 mg QL (240 EA per 30 days) oxycodone oral tablet,oral only,ext.rel.12 hr 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 60 mg, 80 mg PA; QL (60 EA per 30 days) oxycodone-acetaminophen oral tablet mg QL (180 EA per 30 days) oxycodone-acetaminophen oral tablet mg, mg, mg QL (240 EA per 30 days) oxycodone-aspirin oral tablet mg QL (360 EA per 30 days) oxymorphone oral tablet 10 mg, 5 mg QL (120 EA per 30 days) oxymorphone oral tablet extended release 12 hr 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 5 mg, 7.5 mg pentazocine-naloxone oral tablet mg QL (60 EA per 30 days) RELPAX ORAL TABLET 20 MG, 40 MG ST; QL (18 EA per 30 days) rizatriptan oral tablet 10 mg, 5 mg QL (18 EA per 30 days) rizatriptan oral tablet,disintegrating 10 mg, 5 mg QL (18 EA per 30 days) sumatriptan succinate oral tablet 100 mg, 25 mg, 50 mg QL (18 EA per 30 days) sumatriptan succinate subcutaneous pen injector 4 mg/0.5 ml sumatriptan succinate subcutaneous pen injector 6 mg/0.5 ml QL (8 ML per 30 days) sumatriptan succinate subcutaneous solution 6 mg/0.5 ml QL (8 ML per 30 days) tramadol oral tablet 50 mg QL (240 EA per 30 days) tramadol oral tablet extended release 24 hr 100 mg, 200 mg, 300 mg QL (30 EA per 30 days) tramadol oral tablet, er multiphase 24 hr 100 mg, 200 mg, 300 mg QL (30 EA per 30 days) tramadol-acetaminophen oral tablet mg QL (240 EA per 30 days) ZOHYDRO ER ORAL CAPSULE, ORAL ONLY, ER 12HR 10 MG, 15 MG, 20 MG, 30 MG, 40 MG, 50 MG QL (60 EA per 30 days) QL Quantity Limit applies SP Specialty Drug No Cost Share ($0) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 15

16 zolmitriptan oral tablet 2.5 mg, 5 mg ST; QL (18 EA per 30 days) zolmitriptan oral tablet,disintegrating 2.5 mg, 5 mg ST; QL (18 EA per 30 days) ZOMIG NASAL SPRAY,NON-AEROSOL 2.5 MG, 5 MG ST; QL (12 EA per 30 days) ANESTHETICS lidocaine hcl laryngotracheal solution 4 % lidocaine hcl mucous membrane jelly 2 % lidocaine hcl mucous membrane solution 2 %, 4 % (40 mg/ml) lidocaine hcl topical cream 3 % lidocaine hcl topical lotion 3 % lidocaine topical adhesive patch,medicated 5 % PA; QL (90 EA per 30 days) lidocaine topical ointment 5 % PA; QL (150 GM per 30 days) LIDOCAINE VISCOUS MUCOUS MEMBRANE SOLUTION 2 % lidocaine-prilocaine topical cream % lidocaine-prilocaine topical kit % phenazopyridine oral tablet 100 mg, 200 mg SYNERA TOPICAL PATCH, MEDICATED SELF-HEATING MG ANTIALLERGY cromolyn oral concentrate 100 mg/5 ml ANTIARTHRITICS allopurinol oral tablet 100 mg, 300 mg celecoxib oral capsule 100 mg, 200 mg, 400 mg, 50 mg QL (60 EA per 30 days) colchicine oral capsule 0.6 mg colchicine oral tablet 0.6 mg DEPEN TITRATABS ORAL TABLET 250 MG QL Quantity Limit applies SP Specialty Drug No Cost Share ($0) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 16 PA

17 diclofenac sodium oral tablet extended release 24 hr 100 mg diclofenac sodium oral tablet,delayed release (dr/ec) 25 mg, 50 mg, 75 mg ENBREL SUBCUTANEOUS RECON SOLN 25 MG (1 ML) PA; QL (8 EA per 28 days) ENBREL SUBCUTANEOUS SYRINGE 25 MG/0.5ML (0.51) PA; QL (4 ML per 28 days) ENBREL SUBCUTANEOUS SYRINGE 50 MG/ML (0.98 ML) PA; QL (8 ML per 28 days) ENBREL SURECLICK SUBCUTANEOUS PEN INJECTOR 50 MG/ML (0.98 ML) etodolac oral capsule 200 mg, 300 mg etodolac oral tablet 400 mg, 500 mg etodolac oral tablet extended release 24 hr 400 mg, 500 mg, 600 mg fenoprofen oral tablet 600 mg flurbiprofen oral tablet 100 mg, 50 mg HUMIRA PEDIATRIC CROHN'S START SUBCUTANEOUS SYRINGE KIT 40 MG/0.8 ML HUMIRA PEN CROHN'S-UC-HS START SUBCUTANEOUS PEN INJECTOR KIT 40 MG/0.8 ML HUMIRA PEN PSORIASIS-UVEITIS SUBCUTANEOUS PEN INJECTOR KIT 40 MG/0.8 ML HUMIRA PEN SUBCUTANEOUS PEN INJECTOR KIT 40 MG/0.8 ML HUMIRA SUBCUTANEOUS SYRINGE KIT 10 MG/0.2 ML, 20 MG/0.4 ML PA; QL (8 ML per 28 days) PA; QL (3 EA per 180 days) PA; QL (6 EA per 180 days) PA; QL (4 EA per 180 days) PA; QL (4 EA per 28 days) PA; QL (2 EA per 28 days) HUMIRA SUBCUTANEOUS SYRINGE KIT 40 MG/0.8 ML PA; QL (4 EA per 28 days) QL Quantity Limit applies SP Specialty Drug No Cost Share ($0) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 17

18 ibuprofen oral tablet 400 mg, 600 mg, 800 mg indomethacin oral capsule 25 mg, 50 mg ketoprofen oral capsule 50 mg, 75 mg leflunomide oral tablet 10 mg, 20 mg QL (30 EA per 30 days) meclofenamate oral capsule 100 mg, 50 mg meloxicam oral suspension 7.5 mg/5 ml meloxicam oral tablet 15 mg, 7.5 mg nabumetone oral tablet 500 mg, 750 mg naproxen oral tablet 250 mg, 375 mg, 500 mg naproxen oral tablet,delayed release (dr/ec) 375 mg, 500 mg ORENCIA (WITH MALTOSE) INTRAVENOUS RECON SOLN 250 MG ORENCIA CLICKJECT SUBCUTANEOUS AUTO-INJECTOR 125 MG/ML QL Quantity Limit applies SP Specialty Drug No Cost Share ($0) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 18 T1 T1 ORENCIA SUBCUTANEOUS SYRINGE 125 MG/ML PA oxaprozin oral tablet 600 mg piroxicam oral capsule 10 mg, 20 mg probenecid oral tablet 500 mg probenecid-colchicine oral tablet mg RIDAURA ORAL CAPSULE 3 MG SIMPONI ARIA INTRAVENOUS SOLUTION 12.5 MG/ML PA SIMPONI SUBCUTANEOUS PEN INJECTOR 100 MG/ML, 50 MG/0.5 ML SIMPONI SUBCUTANEOUS SYRINGE 100 MG/ML, 50 MG/0.5 ML sulindac oral tablet 150 mg, 200 mg tolmetin oral capsule 400 mg PA PA PA PA

19 tolmetin oral tablet 200 mg, 600 mg ULORIC ORAL TABLET 40 MG, 80 MG ST XELJANZ ORAL TABLET 5 MG PA XELJANZ XR ORAL TABLET EXTENDED RELEASE 24 HR 11 MG ANTIASTHMATICS acetylcysteine solution 100 mg/ml (10 %), 200 mg/ml (20 %) ADVAIR DISKUS INHALATION BLISTER WITH DEVICE MCG/DOSE, MCG/DOSE, MCG/DOSE ADVAIR HFA INHALATION HFA AEROSOL INHALER MCG/ACTUATION, MCG/ACTUATION, MCG/ACTUATION albuterol sulfate inhalation solution for nebulization 0.63 mg/3 ml, 1.25 mg/3 ml, 2.5 mg /3 ml (0.083 %), 2.5 mg/0.5 ml, 5 mg/ml albuterol sulfate oral syrup 2 mg/5 ml albuterol sulfate oral tablet 2 mg, 4 mg aminophylline intravenous solution 250 mg/10 ml aminophylline oral tablet 100 mg, 200 mg ANORO ELLIPTA INHALATION BLISTER WITH DEVICE MCG/ACTUATION ARCAPTA NEOHALER INHALATION CAPSULE, W/INHALATION DEVICE 75 MCG ASMANEX HFA INHALATION HFA AEROSOL INHALER 100 MCG/ACTUATION, 200 MCG/ACTUATION PA QL (60 EA per 30 days) QL (12 GM per 30 days) QL (13 GM per 30 days) QL Quantity Limit applies SP Specialty Drug No Cost Share ($0) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 19

20 ASMANEX TWISTHALER INHALATION AEROSOL POWDR BREATH ACTIVATED 110 MCG (30 DOSES), 220 MCG (120 DOSES), 220 MCG (30 DOSES), 220 MCG (60 DOSES) ATROVENT HFA INHALATION HFA AEROSOL INHALER 17 MCG/ACTUATION BREO ELLIPTA INHALATION BLISTER WITH DEVICE MCG/DOSE, MCG/DOSE BROVANA INHALATION SOLUTION FOR NEBULIZATION 15 MCG/2 ML budesonide inhalation suspension for nebulization 0.25 mg/2 ml, 0.5 mg/2 ml, 1 mg/2 ml COMBIVENT RESPIMAT INHALATION MIST MCG/ACTUATION cromolyn inhalation solution for nebulization 20 mg/2 ml QL Quantity Limit applies SP Specialty Drug No Cost Share ($0) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 20 QL (1 EA per 30 days) QL (26 GM per 30 days) PA QL (8 GM per 30 days) DALIRESP ORAL TABLET 500 MCG QL (30 EA per 30 days) DULERA INHALATION HFA AEROSOL INHALER MCG/ACTUATION, MCG/ACTUATION FLOVENT DISKUS INHALATION BLISTER WITH DEVICE 100 MCG/ACTUATION, 50 MCG/ACTUATION FLOVENT DISKUS INHALATION BLISTER WITH DEVICE 250 MCG/ACTUATION FLOVENT HFA INHALATION HFA AEROSOL INHALER 110 MCG/ACTUATION FLOVENT HFA INHALATION HFA AEROSOL INHALER 220 MCG/ACTUATION FLOVENT HFA INHALATION HFA AEROSOL INHALER 44 MCG/ACTUATION INCRUSE ELLIPTA INHALATION BLISTER WITH DEVICE 62.5 MCG/ACTUATION QL (13 GM per 30 days) QL (60 EA per 30 days) QL (240 EA per 30 days) QL (12 GM per 30 days) QL (24 GM per 30 days) QL (10.6 GM per 30 days)

21 ipratropium bromide inhalation solution 0.02 % ipratropium-albuterol inhalation solution for nebulization 0.5 mg- 3 mg(2.5 mg base)/3 ml levalbuterol hcl inhalation solution for nebulization 0.31 mg/3 ml, 0.63 mg/3 ml, 1.25 mg/0.5 ml, 1.25 mg/3 ml metaproterenol oral syrup 10 mg/5 ml metaproterenol oral tablet 10 mg, 20 mg montelukast oral granules in packet 4 mg montelukast oral tablet 10 mg QL (30 EA per 30 days) montelukast oral tablet,chewable 4 mg, 5 mg QL (30 EA per 30 days) PERFOROMIST INHALATION SOLUTION FOR NEBULIZATION 20 MCG/2 ML QVAR INHALATION AEROSOL 40 MCG/ACTUATION, 80 MCG/ACTUATION SEREVENT DISKUS INHALATION BLISTER WITH DEVICE 50 MCG/DOSE SPIRIVA RESPIMAT INHALATION MIST 1.25 MCG/ACTUATION, 2.5 MCG/ACTUATION SPIRIVA WITH HANDIHALER INHALATION CAPSULE, W/INHALATION DEVICE 18 MCG STIOLTO RESPIMAT INHALATION MIST MCG/ACTUATION STRIVERDI RESPIMAT INHALATION MIST 2.5 MCG/ACTUATION SYMBICORT INHALATION HFA AEROSOL INHALER MCG/ACTUATION, MCG/ACTUATION PA QL (60 EA per 30 days) QL (4 GM per 30 days) QL (30 EA per 30 days) QL (4 GM per 30 days) ST; QL (10.2 GM per 30 days) QL Quantity Limit applies SP Specialty Drug No Cost Share ($0) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 21

22 terbutaline oral tablet 2.5 mg, 5 mg theophylline oral tablet extended release 12 hr 100 mg, 200 mg, 300 mg, 450 mg theophylline oral tablet extended release 24 hr 600 mg theophylline oral tablet extended release 400 mg, 600 mg TUDORZA PRESSAIR INHALATION AEROSOL POWDR BREATH ACTIVATED 400 MCG/ACTUATION VENTOLIN HFA INHALATION HFA AEROSOL INHALER 90 MCG/ACTUATION XOLAIR SUBCUTANEOUS RECON SOLN 150 MG PA QL (36 GM per 30 days) zafirlukast oral tablet 10 mg, 20 mg QL (60 EA per 30 days) ZYFLO CR ORAL TABLET, ER MULTIPHASE 12 HR 600 MG PA; QL (120 EA per 30 days) ZYFLO ORAL TABLET 600 MG PA; QL (120 EA per 30 days) ANTIBIOTICS AK-POLY-BAC OPHTHALMIC OINTMENT ,000 UNIT/GRAM amoxicillin oral capsule 250 mg, 500 mg amoxicillin oral suspension for reconstitution 125 mg/5 ml, 200 mg/5 ml, 250 mg/5 ml, 400 mg/5 ml amoxicillin oral tablet 500 mg, 875 mg amoxicillin oral tablet,chewable 125 mg amoxicillin oral tablet,chewable 250 mg amoxicillin-pot clavulanate oral suspension for reconstitution mg/5 ml, mg/5 ml, mg/5 ml amoxicillin-pot clavulanate oral suspension for reconstitution mg/5 ml amoxicillin-pot clavulanate oral tablet mg T1 T1 T1 T1 QL Quantity Limit applies SP Specialty Drug No Cost Share ($0) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 22

23 amoxicillin-pot clavulanate oral tablet mg, mg amoxicillin-pot clavulanate oral tablet extended release 12 hr 1, mg amoxicillin-pot clavulanate oral tablet,chewable mg, mg ampicillin oral capsule 250 mg, 500 mg ampicillin oral suspension for reconstitution 125 mg/5 ml, 250 mg/5 ml AVAR TOPICAL CLEANSER 10-5 % (W/W) AVAR-E GREEN TOPICAL CREAM 10-5 % (W/W) AVAR-E TOPICAL CREAM 10-5 % (W/W) AZASITE OPHTHALMIC DROPS 1 % azithromycin oral packet 1 gram azithromycin oral suspension for reconstitution 100 mg/5 ml, 200 mg/5 ml azithromycin oral tablet 250 mg, 500 mg, 600 mg bacitracin ophthalmic ointment 500 unit/gram bacitracin-polymyxin b ophthalmic ointment ,000 unit/gram BACTROBAN NASAL NASAL OINTMENT 2 % BENZAMYCINPAK TOPICAL GEL 3-5 % BESIVANCE OPHTHALMIC DROPS,SUSPENSION 0.6 % BLEPHAMIDE S.O.P. OPHTHALMIC OINTMENT % CAPASTAT INJECTION RECON SOLN 1 GRAM CAYSTON INHALATION SOLUTION FOR NEBULIZATION 75 MG/ML T1 PA QL Quantity Limit applies SP Specialty Drug No Cost Share ($0) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 23

24 CEDAX ORAL CAPSULE 400 MG cefaclor oral capsule 250 mg, 500 mg cefadroxil oral capsule 500 mg cefadroxil oral suspension for reconstitution 250 mg/5 ml, 500 mg/5 ml cefadroxil oral tablet 1 gram cefazolin in dextrose (iso-os) intravenous piggyback 1 gram/50 ml cefazolin injection recon soln 1 gram, 100 gram, 300 g, 500 mg cefazolin injection recon soln 10 gram cefdinir oral capsule 300 mg cefdinir oral suspension for reconstitution 125 mg/5 ml, 250 mg/5 ml cefditoren pivoxil oral tablet 200 mg, 400 mg cefixime oral suspension for reconstitution 100 mg/5 ml, 200 mg/5 ml cefpodoxime oral suspension for reconstitution 100 mg/5 ml, 50 mg/5 ml cefpodoxime oral tablet 100 mg, 200 mg cefprozil oral suspension for reconstitution 125 mg/5 ml, 250 mg/5 ml cefprozil oral tablet 250 mg, 500 mg CEFTIN ORAL SUSPENSION FOR RECONSTITUTION 125 MG/5 ML, 250 MG/5 ML ceftriaxone injection recon soln 1 gram, 10 gram, 100 gram, 2 gram, 250 mg, 500 mg cefuroxime axetil oral tablet 250 mg, 500 mg cefuroxime sodium injection recon soln 1.5 gram, 750 mg QL Quantity Limit applies SP Specialty Drug No Cost Share ($0) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 24

25 cefuroxime sodium intravenous recon soln 7.5 gram cephalexin oral capsule 250 mg, 500 mg cephalexin oral suspension for reconstitution 125 mg/5 ml, 250 mg/5 ml chloramphenicol sod succinate intravenous recon soln 1 gram CILOXAN OPHTHALMIC OINTMENT 0.3 % CIPRO HC OTIC DROPS,SUSPENSION % CIPRODEX OTIC DROPS,SUSPENSION % ciprofloxacin (mixture) oral tablet, er multiphase 24 hr 1,000 mg, 500 mg ciprofloxacin hcl ophthalmic drops 0.3 % ciprofloxacin hcl oral tablet 100 mg ciprofloxacin hcl oral tablet 250 mg, 500 mg, 750 mg ciprofloxacin oral suspension,microcapsule recon 250 mg/5 ml, 500 mg/5 ml clarithromycin oral suspension for reconstitution 125 mg/5 ml, 250 mg/5 ml clarithromycin oral tablet 250 mg, 500 mg clarithromycin oral tablet extended release 24 hr 500 mg CLEOCIN VAGINAL SUPPOSITORY 100 MG CLINDACIN ETZ TOPICAL SWAB 1 % CLINDACIN P TOPICAL SWAB 1 % clindacin pac topical kit 1 % clindamycin hcl oral capsule 150 mg, 300 mg clindamycin palmitate hcl oral recon soln 75 mg/5 ml QL Quantity Limit applies SP Specialty Drug No Cost Share ($0) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 25 T1 T1 T1 T1

26 clindamycin phosphate topical gel 1 % clindamycin phosphate topical lotion 1 % clindamycin phosphate topical solution 1 % clindamycin phosphate topical swab 1 % clindamycin phosphate vaginal cream 2 % COLY-MYCIN S OTIC DROPS,SUSPENSION MG/ML CORTISPORIN TOPICAL CREAM , MG/G- UNIT/G-% CORTISPORIN TOPICAL OINTMENT 1 % CORTISPORIN-TC OTIC DROPS,SUSPENSION MG/ML cycloserine oral capsule 250 mg dapsone oral tablet 100 mg, 25 mg demeclocycline oral tablet 150 mg, 300 mg dicloxacillin oral capsule 250 mg, 500 mg DIFICID ORAL TABLET 200 MG PA doxycycline hyclate oral capsule 100 mg, 50 mg doxycycline hyclate oral tablet 100 mg doxycycline monohydrate oral capsule 100 mg, 50 mg doxycycline monohydrate oral tablet 100 mg, 50 mg, 75 mg E.E.S. 200 ORAL SUSPENSION FOR RECONSTITUTION 200 MG/5 ML E.E.S. 400 ORAL TABLET 400 MG E.E.S. GRANULES ORAL SUSPENSION FOR RECONSTITUTION 200 MG/5 ML ERY PADS TOPICAL SWAB 2 % QL Quantity Limit applies SP Specialty Drug No Cost Share ($0) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 26

27 ERY-TAB ORAL TABLET,DELAYED RELEASE (DR/EC) 250 MG, 333 MG, 500 MG ERYTHROCIN (AS STEARATE) ORAL TABLET 250 MG erythromycin ethylsuccinate oral tablet 400 mg erythromycin ophthalmic ointment 5 mg/gram (0.5 %) erythromycin oral capsule,delayed release(dr/ec) 250 mg erythromycin oral tablet 250 mg, 500 mg erythromycin topical solution 2 % erythromycin with ethanol topical gel 2 % erythromycin with ethanol topical solution 2 % erythromycin with ethanol topical swab 2 % erythromycin-benzoyl peroxide topical gel 3-5 % ethambutol oral tablet 100 mg, 400 mg FACTIVE ORAL TABLET 320 MG gatifloxacin ophthalmic drops 0.5 % GENTAK OPHTHALMIC OINTMENT 0.3 % (3 MG/GRAM) gentamicin ophthalmic drops 0.3 % gentamicin ophthalmic ointment 0.3 % (3 mg/gram) gentamicin topical cream 0.1 % gentamicin topical ointment 0.1 % isoniazid oral solution 50 mg/5 ml isoniazid oral tablet 100 mg, 300 mg KETEK ORAL TABLET 300 MG, 400 MG KETEK PAK ORAL TABLET 400 MG QL Quantity Limit applies SP Specialty Drug No Cost Share ($0) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 27

28 levofloxacin ophthalmic drops 0.5 % levofloxacin oral solution 250 mg/10 ml levofloxacin oral tablet 250 mg, 500 mg, 750 mg linezolid oral suspension for reconstitution 100 mg/5 ml PA linezolid oral tablet 600 mg PA meropenem intravenous recon soln 1 gram, 500 mg PA methenamine hippurate oral tablet 1 gram methenamine mandelate oral tablet 1 gram metronidazole oral tablet 250 mg, 500 mg metronidazole vaginal gel 0.75 % minocycline oral capsule 100 mg, 50 mg, 75 mg MONUROL ORAL PACKET 3 GRAM MOXEZA OPHTHALMIC DROPS, VISCOUS 0.5 % mupirocin topical ointment 2 % neomycin oral tablet 500 mg neomycin-bacitracin-poly-hc ophthalmic ointment ,000 mg-unit/g-1% neomycin-bacitracin-polymyxin ophthalmic ointment ,000 mg-unit-unit/g neomycin-polymyxin b-dexameth ophthalmic drops,suspension 3.5mg/ml-10,000 unit/ml-0.1 % neomycin-polymyxin b-dexameth ophthalmic ointment 3.5 mg/g- 10,000 unit/g-0.1 % neomycin-polymyxin-gramicidin ophthalmic drops 1.75 mg-10,000 unit-0.025mg/ml neomycin-polymyxin-hc otic drops,suspension ,000-1 mg/ml-unit/ml-% QL Quantity Limit applies SP Specialty Drug No Cost Share ($0) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 28

29 neomycin-polymyxin-hc otic solution ,000-1 mg/ml-unit/ml- % nitrofurantoin macrocrystal oral capsule 100 mg, 50 mg nitrofurantoin monohyd/m-cryst oral capsule 100 mg nitrofurantoin oral suspension 25 mg/5 ml ofloxacin ophthalmic drops 0.3 % ofloxacin oral tablet 300 mg, 400 mg ofloxacin otic drops 0.3 % PASER ORAL GRANULES DR FOR SUSP IN PACKET 4 GRAM penicillin v potassium oral recon soln 125 mg/5 ml, 250 mg/5 ml penicillin v potassium oral tablet 250 mg, 500 mg polymyxin b sulfate injection recon soln 500,000 unit polymyxin b sulf-trimethoprim ophthalmic drops 10,000 unit- 1 mg/ml PRIFTIN ORAL TABLET 150 MG pyrazinamide oral tablet 500 mg rifabutin oral capsule 150 mg RIFAMATE ORAL CAPSULE MG rifampin oral capsule 150 mg, 300 mg RIFATER ORAL TABLET MG ROSANIL TOPICAL CLEANSER 10-5 % (W/W) ROSULA CLEANSING CLOTHS TOPICAL PADS, MEDICATED 10-5 % silver sulfadiazine topical cream 1 % QL Quantity Limit applies SP Specialty Drug No Cost Share ($0) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 29

30 SIRTURO ORAL TABLET 100 MG SS 10-2 TOPICAL CLEANSER 10-2 % SSD TOPICAL CREAM 1 % SSS 10-5 TOPICAL CREAM 10-5 % (W/W) SSS 10-5 TOPICAL FOAM 10-5 % streptomycin intramuscular recon soln 1 gram sulfacetamide sodium ophthalmic drops 10 % sulfacetamide sodium ophthalmic ointment 10 % sulfacetamide sodium-sulfur topical cleanser 10-2 %, 10-5 % (w/w), %, % sulfacetamide sodium-sulfur topical cream 10-2 %, 10-5 % (w/w), % sulfacetamide sodium-sulfur topical foam 10-5 % sulfacetamide sodium-sulfur topical lotion 10-5 % (w/v) sulfacetamide sodium-sulfur topical lotion 10-5 % (w/w), % sulfacetamide sodium-sulfur topical pads, medicated 10-4 % sulfacetamide sodium-sulfur topical suspension 10-5 % sulfacetamide sod-sulfur-urea topical cleanser % sulfadiazine oral tablet 500 mg sulfamethoxazole-trimethoprim intravenous solution mg/5 ml sulfamethoxazole-trimethoprim oral suspension mg/5 ml sulfamethoxazole-trimethoprim oral tablet mg, mg SULFAMYLON TOPICAL CREAM 85 MG/G SUPRAX ORAL CAPSULE 400 MG T1 QL Quantity Limit applies SP Specialty Drug No Cost Share ($0) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 30

31 SUPRAX ORAL SUSPENSION FOR RECONSTITUTION 500 MG/5 ML SUPRAX ORAL TABLET,CHEWABLE 100 MG, 200 MG tetracycline oral capsule 250 mg, 500 mg THALOMID ORAL CAPSULE 100 MG, 150 MG, 200 MG, 50 MG THERMAZENE TOPICAL CREAM 1 % TOBRADEX OPHTHALMIC OINTMENT % TOBRADEX ST OPHTHALMIC DROPS,SUSPENSION % tobramycin in % nacl inhalation solution for nebulization 300 mg/5 ml tobramycin ophthalmic drops 0.3 % tobramycin-dexamethasone ophthalmic drops,suspension % TRECATOR ORAL TABLET 250 MG trimethoprim oral tablet 100 mg vancomycin intravenous recon soln 1,000 mg, 500 mg QL Quantity Limit applies SP Specialty Drug No Cost Share ($0) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 31 vancomycin oral capsule 125 mg, 250 mg PA VIGAMOX OPHTHALMIC DROPS 0.5 % XIFAXAN ORAL TABLET 200 MG PA; QL (9 EA per 30 days) XIFAXAN ORAL TABLET 550 MG PA; QL (90 EA per 30 days) ZYLET OPHTHALMIC DROPS,SUSPENSION % ANTICOAGULANTS ELIQUIS ORAL TABLET 2.5 MG, 5 MG PA PA

32 enoxaparin subcutaneous solution 300 mg/3 ml QL (24 ML per 30 days) enoxaparin subcutaneous syringe 100 mg/ml, 150 mg/ml QL (28 ML per 30 days) enoxaparin subcutaneous syringe 120 mg/0.8 ml, 80 mg/0.8 ml QL (22.4 ML per 30 days) enoxaparin subcutaneous syringe 30 mg/0.3 ml QL (8.4 ML per 30 days) enoxaparin subcutaneous syringe 40 mg/0.4 ml QL (11.2 ML per 30 days) enoxaparin subcutaneous syringe 60 mg/0.6 ml QL (16.8 ML per 30 days) fondaparinux subcutaneous syringe 10 mg/0.8 ml PA; QL (24 ML per 30 days) fondaparinux subcutaneous syringe 2.5 mg/0.5 ml PA; QL (15 ML per 30 days) fondaparinux subcutaneous syringe 5 mg/0.4 ml PA; QL (12 ML per 30 days) fondaparinux subcutaneous syringe 7.5 mg/0.6 ml PA; QL (18 ML per 30 days) heparin (porcine) injection cartridge 5,000 unit/ml (1 ml) heparin (porcine) injection solution 10,000 unit/ml, 20,000 unit/ml, 5,000 unit/ml heparin (porcine) injection syringe 20,000 unit/ml heparin, porcine (pf) injection solution 1,000 unit/ml, 5,000 unit/0.5 ml heparin, porcine (pf) injection syringe 5,000 unit/0.5 ml JANTOVEN ORAL TABLET 1 MG, 10 MG, 2 MG, 2.5 MG, 3 MG, 4 MG, 5 MG, 6 MG, 7.5 MG PRADAXA ORAL CAPSULE 110 MG, 150 MG, 75 MG warfarin oral tablet 1 mg, 10 mg, 2 mg, 2.5 mg, 3 mg, 4 mg, 5 mg, 6 mg, 7.5 mg XARELTO ORAL TABLET 10 MG, 15 MG, 20 MG XARELTO ORAL TABLETS,DOSE PACK 15 MG (42)- 20 MG (9) ANTIDOTES MOVANTIK ORAL TABLET 12.5 MG, 25 MG PA QL Quantity Limit applies SP Specialty Drug No Cost Share ($0) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 32 T1 T1

33 naloxone injection syringe 1 mg/ml naltrexone oral tablet 50 mg ANTIFUNGALS amphotericin b injection recon soln 50 mg CICLODAN TOPICAL SOLUTION 8 % ciclopirox topical cream 0.77 % ciclopirox topical gel 0.77 % ciclopirox topical shampoo 1 % ciclopirox topical solution 8 % ciclopirox topical suspension 0.77 % ciclopirox-ure-camph-menth-euc topical solution 8 % ciclopirox-vite-nail lacq remo topical kit 8-5 % clotrimazole mucous membrane troche 10 mg clotrimazole topical cream 1 % clotrimazole topical solution 1 % clotrimazole-betamethasone topical cream % clotrimazole-betamethasone topical lotion % CRESEMBA INTRAVENOUS RECON SOLN 372 MG PA CRESEMBA ORAL CAPSULE 186 MG PA econazole topical cream 1 % ERTACZO TOPICAL CREAM 2 % PA EXELDERM TOPICAL CREAM 1 % EXELDERM TOPICAL SOLUTION 1 % QL Quantity Limit applies SP Specialty Drug No Cost Share ($0) _MPINFO133 (11/2016) 2017 QHP 5 Tier Formulary, Version 4 Page 33